APA (7th ed.) Citation

Wang, M., Xu, X., Wang, K., Diao, Y., Xu, J., Gu, L., . . . Yang, T. (2024). Conversion therapy for advanced hepatocellular carcinoma in the era of precision medicine: Current status, challenges and opportunities. Cancer science, 115(7), 2159-2169. https://doi.org/10.1111/cas.16194

Chicago Style (17th ed.) Citation

Wang, Ming‐Da, et al. "Conversion Therapy for Advanced Hepatocellular Carcinoma in the Era of Precision Medicine: Current Status, Challenges and Opportunities." Cancer Science 115, no. 7 (2024): 2159-2169. https://doi.org/10.1111/cas.16194.

MLA (9th ed.) Citation

Wang, Ming‐Da, et al. "Conversion Therapy for Advanced Hepatocellular Carcinoma in the Era of Precision Medicine: Current Status, Challenges and Opportunities." Cancer Science, vol. 115, no. 7, 2024, pp. 2159-2169, https://doi.org/10.1111/cas.16194.